Atreca, Inc.
Atreca, Inc. (BCEL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bcel · stock forecast · 8 analysts (3M) · FMP · updated Mar 9, 2025
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$4.00
Consensus
$4.00
+4344.4% upside
Low
$4.00
Median: $4 · Last Close: $0.09
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.09 | ↑ 0.13% |
1-day model range: $0.09–$0.09. Peak: $0.09 (+0.13%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · BCEL · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-14 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2023-08-13 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2023-08-11 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-08-11 | Stifel | Downgrade ↓ | Buy→Hold |
| 2023-08-10 | Stifel | Downgrade ↓ | Buy→Hold |
| 2023-08-10 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-06-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-11 | Stifel | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Atreca, Inc. (BCEL) stock. Of the recent 29 rating actions, 0 were upgrades and 8 were downgrades. 8 analysts currently cover BCEL.
Analyst Recommendation Trends
BCEL analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$1M
↓ 96.5% YoY
Revenue Next Year
$50M
↑ 8099.4% YoY
EPS This Year
$-2.04
EPS Next Year
$-0.86
↓ 57.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast BCEL EPS of $-2.04 for the current fiscal year, based on estimates from 1 analysts. The BCEL revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BCEL stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BCEL price target is $4.00 (+4344.4% upside), with an analyst consensus of Buy.
The BCEL short-term stock prediction for tomorrow is $0.09 (+0.13%).
Atreca, Inc. trades on NASDAQ under the ticker BCEL. The BCEL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
BCEL forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month BCEL price target is $4.00, with a high forecast of $4.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +4344.4% potential upside from the current price of $0.09.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.